| Primary |
| Ill-defined Disorder |
85.7% |
| Hypertension |
9.5% |
| Arthralgia |
2.4% |
| Prophylaxis |
2.4% |
|
| Renal Failure |
50.0% |
| Asthma |
16.7% |
| Hyperaldosteronism |
16.7% |
| Hyperkalaemia |
16.7% |
|
| Secondary |
| Renal Failure Chronic |
38.5% |
| Essential Hypertension |
23.1% |
| Hypertension |
15.4% |
| Acute Coronary Syndrome |
7.7% |
| Hyperparathyroidism Secondary |
7.7% |
| Prophylaxis |
7.7% |
|
| Dizziness |
33.3% |
| Renal Failure Chronic |
33.3% |
| Sudden Death |
33.3% |
|
| Concomitant |
| Hypertension |
31.5% |
| Drug Use For Unknown Indication |
10.1% |
| Product Used For Unknown Indication |
4.9% |
| Atrial Fibrillation |
4.7% |
| Ill-defined Disorder |
4.7% |
| Prophylaxis |
4.4% |
| Rheumatoid Arthritis |
4.2% |
| Acute Coronary Syndrome |
3.9% |
| Type 2 Diabetes Mellitus |
3.7% |
| Diabetes Mellitus |
3.6% |
| Depression |
3.4% |
| Myocardial Ischaemia |
3.4% |
| Coronary Artery Disease |
2.9% |
| Myocardial Infarction |
2.4% |
| Cardiac Failure Chronic |
2.3% |
| Angina Pectoris |
2.1% |
| Hyperlipidaemia |
2.1% |
| Hypercholesterolaemia |
2.0% |
| Thrombosis Prophylaxis |
2.0% |
| Spondylitis |
1.6% |
|
| Vomiting |
8.8% |
| Cholesterol Granuloma |
6.3% |
| Pancreatitis |
6.3% |
| Sudden Death |
6.3% |
| Tachycardia |
6.3% |
| Diarrhoea |
5.0% |
| Dyspnoea |
5.0% |
| Intraocular Pressure Increased |
5.0% |
| Rash |
5.0% |
| Renal Failure |
5.0% |
| Renal Failure Acute |
5.0% |
| Sepsis |
5.0% |
| Urine Analysis Abnormal |
5.0% |
| Adverse Event |
3.8% |
| Dermatitis Exfoliative |
3.8% |
| Ischaemic Stroke |
3.8% |
| Jaundice |
3.8% |
| Mucosal Inflammation |
3.8% |
| Myocardial Infarction |
3.8% |
| Myocardial Ischaemia |
3.8% |
|
